Harvard Bioscience (HBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,922 | -865 | -4,307 | -19,039 | 2,355 |
| Depreciation Amortization | 8,499 | 3,845 | 4,365 | 4,659 | 3,939 |
| Income taxes - deferred | -2,861 | -1,584 | -279 | 15,116 | 1,412 |
| Accounts receivable | -2,792 | 196 | 566 | -1,340 | -735 |
| Accounts payable and accrued liabilities | N/A | -918 | -2,413 | 2,577 | 1,069 |
| Other Working Capital | -1,675 | -3,811 | -41 | -2,719 | -4,514 |
| Other Operating Activity | 4,635 | 4,194 | 7,492 | 1,451 | 825 |
| Operating Cash Flow | $2,884 | $1,057 | $5,383 | $705 | $4,351 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -986 | -878 | -1,445 | -2,954 | -864 |
| Net Acquisitions | -52,794 | N/A | 1,417 | -4,545 | -12,653 |
| Other Investing Activity | -16 | -39 | -34 | -18 | 0 |
| Investing Cash Flow | $-53,796 | $-917 | $-62 | $-7,517 | $-13,517 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 70,700 | 2,750 | 4,000 | 5,800 | 2,200 |
| Debt Repayment | -20,198 | -4,702 | -9,050 | -8,350 | -5,500 |
| Common Stock Issued | 4,557 | 160 | 182 | 2,042 | 2,066 |
| Other Financing Activity | -2,006 | 0 | 0 | -32 | 0 |
| Financing Cash Flow | $53,053 | $-1,792 | $-4,868 | $-540 | $-1,234 |
| Exchange Rate Effect | 299 | 1,789 | -1,601 | -38 | -1,237 |
| Beginning Cash Position | 5,733 | 5,596 | 6,744 | 14,134 | 25,771 |
| End Cash Position | 8,173 | 5,733 | 5,596 | 6,744 | 14,134 |
| Net Cash Flow | $2,440 | $137 | $-1,148 | $-7,390 | $-11,637 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,884 | 1,057 | 5,383 | 705 | 4,351 |
| Capital Expenditure | -986 | -890 | -1,445 | -2,960 | -2,005 |
| Free Cash Flow | 1,898 | 167 | 3,938 | -2,255 | 2,346 |